Login

Forgot password?
Sign up today and your first download is free.
REGISTER

Rx Drugs

May 30, 2018 | Daily News

After President Donald Trump signed Wednesday (May 30) the national Right to Try law passed by the House last week, FDA said it stands ready to enact the law but for now urged staff to refer patients to individual drug companies and to not provide drug companies with advice on complying with the statute.

May 30, 2018 | Daily News

President Donald Trump promised Wednesday (May 30) that drug companies would voluntarily lower drug prices in two weeks -- a comment that caught lobbyists off guard, and left some cautioning against taking Trump’s comments literally.

May 30, 2018 | Daily News

The Senate Finance Committee in the coming weeks will mark up more than a dozen bills aimed at reducing opioid abuse in Medicare and Medicaid, including several that resemble measures recently approved by the two House committees working on opioid legislation.

May 30, 2018 | Daily News

Hospitals and addiction treatment groups back a bipartisan, bicameral bill that would increase the number of Medicare-funded graduate medical education residency slots at hospitals that have or are establishing approved residency programs in addiction medicine, addiction psychiatry or pain management.

May 29, 2018 | Daily News

Ahead of a key Senate committee hearing on President Donald Trump's plan to lower drug prices, Sen. Bill Cassidy (R-LA) released a white paper Tuesday (May 29) floating a number of ideas for lowering drug costs, including: passing on drug rebates to beneficiaries at the pharmacy counter, moving toward international reference pricing and cracking down on brand company efforts to block generic competition via abuses of Risk Evaluation and Mitigation Strategies (REMS).

May 25, 2018 | Daily News

The Senate Judiciary Committee on Thursday (May 24) voted to send five opioid-related bills to the Senate floor, including a measure that would require the Drug Enforcement Administration (DEA) to consider diversion, abuse and other public health impacts of opioids when setting annual production quotas for manufacturers.

May 25, 2018 | Daily News

The White House Office of Management and Budget on Thursday (May 24) began reviewing a final rule to again delay implementation of the 340B ceiling price and penalties rule.

May 25, 2018 | Daily News

A coalition of the nation's largest pharmacies are suing Allergan over what they alleged is a multiyear anticompetitive scheme to shield the company's dry eye drug Restasis from generic competition.

May 25, 2018 | Daily News

Spending on cancer drugs doubled in the past five years and is expected to double again in the next five years, but employers paid most of the increased costs.

May 24, 2018 | Daily News

The Congressional Budget Office believes the president's proposal to eliminate low-income beneficiaries' cost sharing for generic drugs would cost more than $18 billion dollars over 10 years, despite the fact that the White House Office of Management and Budget previously said the proposal would be nearly budget neutral.

May 24, 2018 | Daily News

A new survey published by a precision medicine stakeholder group shows that, while most Americans have never heard of personalized or precision medicine, most had positive reactions when they were told what it was.

May 24, 2018 | Daily News

FDA Commissioner Scott Gottlieb is inviting internet stakeholders, including senior executives of major search engines, social media platforms, domain names registries and online marketplaces, to an opioid summit on June 27 to discuss ways to reduce illegal online opioid sales.

May 24, 2018 | Daily News

HHS Secretary Alex Azar will testify June 12 on the president’s drug-price plan at a Senate health committee hearing, according to a committee release.

May 24, 2018 | Daily News

CMS might consider making plans factor drug rebates and pharmacy price concessions in Medicare Advantage and Part D bids to save Medicare beneficiaries money at the pharmacy counter, Washington Analysis states in a note to its clients.

May 24, 2018 | Daily News

Hospitals say there is no justification for the Health Resources and Services Administration's plan to delay for a fifth time implementing a rule on manufacturer penalties and ceiling price calculations in the 340B program, and they take issue with HRSA's claim that the delay won't hurt providers that may be overcharged by drug makers.

May 23, 2018 | Daily News

An Avalere analysis that asserts generic drug costs are rising for seniors in Part D due to plans putting generics on higher-cost tiers is “mostly founded on general speculation versus reliable fact,” a spokesperson for America’s Health Insurance Plans alleges.

May 23, 2018 | Daily News

The Senate health committee on Wednesday (May 23) voted 22-1 in favor of legislation reauthorizing the Pandemic and All-Hazards Preparedness and Advancing Innovation Act, and Committee Chair Lamar Alexander (R-TN) said he hopes to get the bill through the Senate floor before programs expire in September.

May 23, 2018 | Daily News

CMS will soon request proposals from third parties to buy drugs on behalf of physicians, which is a defunct program HHS is reviving for the first time since it failed more than a decade ago.

May 23, 2018 | Daily News

FDA commissioner Scott Gottlieb announced Tuesday (May 22) that his agency will soon be releasing a suite of draft guidances outlining potential accelerated approval endpoints for certain gene therapy products, starting first with products that treat hemophilia.

May 22, 2018 | Daily News

A Senate Appropriations subcommittee on Tuesday (May 22) voted unanimously to send to the full committee a fiscal 2019 FDA funding bill that appears to give the agency $163 million more than its current level but still less than requested by the administration, coming after House appropriators also agreed to hike FDA spending.

Pages